Dienogest suppresses the activation of primordial follicles and preserves the primordial follicle stockpile for fertility in mice
article
OA: bronze
CC0
⤵ 1 in-corpus citation
AI-generated summary
Dienogest administration in mice reduced primordial follicle activation and conserved their number, potentially preserving fertility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The aim of the present study was to characterize the effect of long-term usage of dienogest, a fourth-generation progestin that possesses progestogen and anti-androgen activities, on the stockpile of oocytes and fertility after administration. Female ICR mice (100 days old) were divided into a dienogest group and a control group. The mice received 16 consecutive subcutaneous injections of 5 mg dienogest dissolved in corn oil or corn oil as a vehicle control every 4 days. The mice treated with dienogest had more total offspring and larger litter sizes after the final administration than the mice treated with the vehicle control. Greater numbers of primordial follicles were detected at both 4 and 80 days after the final administration. No significant differences were found in serum anti-Müllerian hormone concentrations at 4 and 80 days after the final dienogest administration. The ratio of primary to primordial follicles was decreased in 3-day-old newborn ovaries cultured for 4 days with dienogest (10-7, 10-6 and 10-5 mol/l) compared with ovaries cultured without dienogest. The results of the present study indicate that dienogest suppresses the activation of primordial follicles during its administration and preserves the primordial follicle stockpile and subsequent fertility in mice.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial via openalex
- New progestagens for contraceptive use via openalex
- Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats via openalex
- doi:10.1677/jme.0.0170055 via openalex
- doi:10.1016/j.jri.2009.09.002 via openalex
- doi:10.3109/13697137.2016.1164133 via openalex
- doi:10.1186/s13048-016-0246-7 via openalex
- doi:10.1210/en.2009-1176 via openalex
- doi:10.1093/humrep/14.9.2328 via openalex
- doi:10.1210/en.2009-0751 via openalex
- doi:10.1172/jci107194 via openalex
- doi:10.1530/rep-13-0181 via openalex
- doi:10.1093/molehr/gat065 via openalex
- doi:10.1210/er.2014-1020 via openalex
- doi:10.1007/bf03345616 via openalex
- doi:10.1016/j.fertnstert.2012.11.034 via openalex
- doi:10.1126/scitranslmed.3005402 via openalex
- doi:10.1016/j.cca.2014.07.029 via openalex
- doi:10.1371/journal.pone.0008772 via openalex
- doi:10.1172/jci119074 via openalex
- doi:10.1530/jrf.0.0880399 via openalex
- doi:10.1093/humupd/dmv037 via openalex
- doi:10.1038/nrendo.2011.224 via openalex
- doi:10.1007/s10735-016-9692-1 via openalex
- W2181155622 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T06:03:29.626429+00:00
License: CC0
· commercial use OK